dipyridamole has been researched along with Periphlebitis in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Periphlebitis: Periphlebitis is inflammation of the outer coat of a vein or of tissues surrounding the vein.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ogston, D | 1 |
| Douglas, AS | 1 |
1 review available for dipyridamole and Periphlebitis
| Article | Year |
|---|---|
Anticoagulant and thrombolytic drugs. II. Clinical aspects.
Topics: Administration, Oral; Adult; Anticoagulants; Blood Coagulation Factors; Coronary Disease; Coumarins; | 1971 |